This article is more than 5 years old. Information may no longer be current.
AMO completes Visx acquisition
Click Here to Manage Email Alerts
SANTA ANA, Calif. — Advanced Medical Optics has officially completed its merger with Visx, the company announced in a press release. Both companies’ shareholders approved the transaction on May 26.
“The acquisition of Visx transforms AMO into the world’s leading refractive surgical company and demonstrates our commitment to this fast-growing market,” Jim Mazzo, president and chief executive officer of AMO, said in the release. “As we combine Visx with AMO, we will continue to focus our R&D investment toward discovering new technologies that optimize vision for people of all ages.”
Among the products the company will now market: the Star S4 laser system, the WaveScan wavefront system, the CustomVue custom ablation system and the Amadeus II microkeratome in addition to the Verisyse, ReZoom, Array and Tecnis IOLs.
AMO had announced in early November its intentions to merge with the refractive laser manufacturer in a cash and stock transaction. Under terms of the agreement, Visx stockholders received 0.552 shares of AMO stock and $3.50 in cash for every share of Visx common stock they owned. AMO bought Visx for about $1.27 billion, according to market reports. AMO’s shareholders own about 58.5% of the company, with Visx shareholders owning about 41.5%. Beginning June 8, AMO will begin trading on the New York Stock Exchange under Visx’s old ticker, EYE.
Liz Davila, former chairman and chief executive officer of Visx, has joined AMO’s board of directors, while former Visx president and chief operating officer Doug Post has joined AMO as its president of the Americas region, according to the release.